Home Overview Press Room Blog Publications For Students about us
Search

Global Governance : Displaying 11-20 of 420


Four Steps Forward, One Leap Back on Global Governance of Synthetic Biologyby ETC GroupETC GroupDecember 19th, 2016196 countries meeting at the UN Convention on Biodiversity grappled with how synthetic biology and other risky technologies threaten biodiversity, local economies, and the rights of farmers and Indigenous Peoples.
Bioterrorism And Gene Editing: Can Crispr Tool Be Used As Biological Weapon In War?by Himanshu GoenkaIB TimesDecember 14th, 2016Given its broad distribution, low cost, and accelerated pace of development, deliberate or unintentional misuse of gene editing might have far-reaching economic and national security implications.
We Launched a New Website! Surrogacy360by Kiki Zeldes, Biopolitical Times guest contributorDecember 14th, 2016Surrogacy360 provides accurate information and resources, free of commercial interest, for people considering surrogacy outside the United States.
Biopolitical News of 2016by Pete Shanks, Leah Lowthorp & Marcy DarnovskyBiopolitical TimesDecember 13th, 2016We highlight 2016’s trends in and top news stories about human biotech developments.
With 21st Century Cures Act, the Future of Regenerative Medicine Is “Inject and See”by Megan MoltenWiredDecember 13th, 2016Critics say it’s deregulation in sheep’s clothing — and worry that both science and patients will suffer.
Exclusive: Mexico clinic plans 20 ‘three-parent’ babies in 2017by Michael Le PageNew ScientistDecember 9th, 2016Mexico has no specific regulations governing mitochondrial replacement or assisted reproduction.
Cambodia charges Australian nurse for running surrogacy clinicby Prak Chan ThulReutersNovember 21st, 2016As many South Asian countries take steps to clamp down on commercial surrogacy tourism, stakeholders are confronted with charges.
Seeding Doubt: How Self-Appointed Guardians of “Sound Science” Tip the Scales Toward Industryby Liza GrossThe InterceptNovember 15th, 2016Sense About Science has downplayed concerns about industry-funded research and promoted science that favors private interests over public health.
Disgraced stem-cell entrepreneur under fresh investigationby Alison AbbottNature NewsNovember 14th, 2016Davide Vannoni was barred from offering a controversial stem-cell therapy in Italy in 2015, but may be continuing his work abroad.
Stem Cell Clinics Promise Miracle Cures, but at What Cost to Patients?by Philip PerryBig ThinkNovember 13th, 2016Taking advantage of a regulatory loophole, hundreds of clinics with virtually no oversight are offering stem cell therapies which are virtually untested, and make unsubstantiated claims about helping patients overcome disease.
Displaying 11-20 of 420  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760